(Adnkronos) - La Fondazione IG-IBD ha come obiettivo quello di sensibilizzare le istituzioni verso le malattie infiammatorie croniche intestinali, quali la malattia di Crohn e la colite ulcerosa e di supportare, stimolare la ricerca scientifica in questo campo perché i pazienti che si ammalano di queste patologie sono sempre più numerosi quindi è sempre più necessario disporre di metodiche diagnostiche e soprattutto terapie innovative” Sono le parole di Sandro Ardizzone, presidente Fondazione IG-IBD, ospite al XV Congresso Nazionale IG-IBD, il Gruppo Italiano per lo Studio delle Malattie Infiammatorie Croniche Intestinali, in corso a Riccione.
Category
🗞
NewsTranscript
00:00The GbD and TSE Foundation is a newly-founded foundation, which was born for the will of the scientific association GbD and which aims to sensitize the institutions towards chronic intestinal inflammatory diseases, such as Crohn's disease and colitis ulcerosa,
00:22and to support and stimulate scientific research in this field, which is extremely stimulating in itself, but which requires it, because the number of patients suffering from these pathologies is increasing.
00:37In our country it is estimated, I say estimated because we do not have precise numbers, that there are about 270-300 thousand patients affected by chronic intestinal inflammatory diseases and about 7 million are patients who suffer from them in the world.
00:52Over the following decades, it is thought that we will add figures of 30 million and even 50 million patients affected by these diseases.
01:01It is evident that something has to be done, especially in our country, because it is important to have real, reliable data.
01:11A priority of the foundation is to collect data on the cases of Crohn's disease and colitis ulcerosa, but also on those that, in the meantime, have been found in various centers, in order to have the most precise photograph possible.